The role of imaging in diagnosing neuromyelitis optica spectrum disorder

Multiple Sclerosis and Related Disorders

Volumn 3, Issue 3, 2014, Pages 284-293

  Matthews, Lucy A ^a,b   Palace, Jacqueline A ^a,b  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Imaging; MRI; Multiple sclerosis; Neuromyelitis optica

Indexed keywords

AQUAPORIN 4 ANTIBODY; BIOLOGICAL MARKER;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; BRAIN DAMAGE; CLINICAL FEATURE; CONE BEAM COMPUTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DIFFUSION TENSOR IMAGING; EARLY DIAGNOSIS; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE ANALYSIS; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NEUROMYELITIS OPTICA SPECTRUM DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPTIC NERVE; OPTIC NEURITIS; QUANTITATIVE ANALYSIS; REVIEW; SPINAL CORD; SPINAL CORD LESION;

EID: 84896542091     PISSN: 22110348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msard.2013.11.003     Document Type: Review

References (74)

1. Apiwattanakul M, Popescu BF, Matiello M, Weinshenker BG, Lucchinetti CF, Lennon VA, et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol 2010;68(5):757-61.
2. Aboul-Enein F, Krssak M, Hoftberger R, Prayer D, Kristoferitsch W. Diffuse white matter damage is absent in neuromyelitis optica. AJNR: Am J Neuroradiol 2010;31(1):76-9.
3. Bot JC, Barkhof F, Polman CH, Lycklama a Nijeholt GJ, de Groot V, Bergers E, et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 2004;62(2):226-33. (Pubitemid 38167129)
4. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120(Pt 11):2059-69. (Pubitemid 27493740)
5. Bonavita S, Gallo A, Sacco R, Corte MD, Bisecco A, Docimo R, et al. Distributed changes in default-mode resting-state connectivity in multiple sclerosis. Mult Scler 2011;17(4):411-22.
6. Cabrera-Gomez J, Saiz-Hinarejos A, Graus F, Gonzalez-Quevedo A, Rodriguez-Rojas R, Quevedo-Sotolongo L, et al. Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders. Mult Scler 2008;14(2):248-51. (Pubitemid 351639635)
7. Chard DT, Griffin CM, McLean MA, Kapeller P, Kapoor R, Thompson AJ, et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 2002;125(Pt 10):2342-52.
8. Ciccarelli O, Thomas D, De Vita E, Wheeler-Kingshott C, Kachramanoglou C, Kapoor R, et al. Low myo-inositol indicating astrocytic damage in a case series of NMO. Ann Neurol 2013. Apr 3.
9. Calabrese M, Oh MS, Favaretto A, Rinaldi F, Poretto V, Alessio S, et al. No MRI evidence of cortical lesions in neuromyelitis optica. Neurology 2012;79(16):1671-6.
10. Downer JJ, Leite MI, Carter R, Palace J, Kuker W, Quaghebeur G. Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete? Neuroradiology 2012 Apr;54(4):79-85.
11. Davie CA, Barker GJ, Thompson AJ, Tofts PS, McDonald WI, Miller DH. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;63(6):736-42. (Pubitemid 27520749)
12. Dalton CM, Chard DT, Davies GR, Miszkiel KA, Altmann DR, Fernando K, et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004;127(Pt 5):1101-7. (Pubitemid 38623045)
13. Duan Y, Liu Y, Liang P, Jia X, Yu C, Qin W, et al. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study. Eur J Radiol 2012 Feb;81(2):e110-4.
14. de Seze J, Stojkovic T, Ferriby D, Gauvrit JY, Montagne C, Mounier-Vehier F, et al. Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 2002;197(1-2):57-61. (Pubitemid 34462145)
15. de Seze J, Blanc F, Kremer S, Collongues N, Fleury M, Marcel C, et al. Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica. J Neurol Neurosurg Psychiatry 2010;81(4):409-11.
16. Filippi M, Rocca MA, Moiola L, Martinelli V, Ghezzi A, Capra R, et al. MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica. Neurology 1999;53(8):1705-10. (Pubitemid 29530343)
17. Filippi M, Rocca MA, Falini A, Caputo D, Ghezzi A, Colombo B, et al. Correlations between structural CNS damage and functional MRI changes in primary progressive MS. Neuroimage 2002;15(3):537-46. (Pubitemid 34852521)
18. Griffin CM, Chard DT, Ciccarelli O, Kapoor B, Barker GJ, Thompson AI, et al. Diffusion tensor imaging in early relapsing-remitting multiple sclerosis. Mult Scler 2001;7(5):290-7. (Pubitemid 33026254)
19. Hickman SJ, Toosy AT, Miszkiel KA, Jones SJ, Altmann DR, MacManus DG, et al. Visual recovery following acute optic neuritis - a clinical, electrophysiological and magnetic resonance imaging study. J Neurol 2004;251(8):996-1005. (Pubitemid 39119319)
20. Ito S, Mori M, Makino T, Hayakawa S, Kuwabara S. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol 2009;66(3):425-8.
21. Ikeda K, Ito H, Hidaka T, Takazawa T, Sekine T, Yoshii Y, et al. Repeated non-enhancing tumefactive lesions in a patient with a neuromyelitis optica spectrum disorder. Intern Med 2011;50(9):1061-4.
22. Isose S, Mori M, Takahashi N, Ito S, Kuwabara S. Neurological pictures. Clumsy hand syndrome due to a localised cortical lesion in the primary sensory cortex in neuromyelitis optica. J Neurol Neurosurg Psychiatry 2011;82(5):559-60.
23. Kim W, Kim SH, Lee SH, Li XF, Kim HJ. Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder. Mult Scler 2011 Sep;17(9):1107-12.
24. Krampla W, Aboul-Enein F, Jecel J, Lang W, Fertl E, Hruby W, et al. Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study. Eur Radiol 2009;19(10):2535-43.
25. Kitley JL, Leite MI, George JS, Palace JA. The differential diagnosis of longitudinally extensive transverse myelitis. Mult Scler 2012 Mar;18(3):271-85.
26. Kidd D, Burton B, Plant GT, Graham EM. Chronic relapsing inflammatory optic neuropathy (CRION). Brain 2003;126(Pt 2):276-84. (Pubitemid 36172735)
27. Kim JE, Kim SM, Ahn SW, Lim BC, Chae JH, Hong YH, et al. Brain abnormalities in neuromyelitis optica. J Neurol Sci 2011;302(1-2):43-8.
28. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364(9451):2106-12. (Pubitemid 39626806)
29. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005;202(4):473-7. (Pubitemid 41186945)
30. Lu Z, Qiu W, Zou Y, Lv K, Long Y, You W, et al. Characteristic linear lesions and longitudinally extensive spinal cord lesions in Chinese patients with neuromyelitis optica. J Neurol Sci 2010;293(1-2):92-6.
31. Li Y, Xie P, Lv F, Mu J, Li Q, Yang Q, et al. Brain magnetic resonance imaging abnormalities in neuromyelitis optica. Acta Neurol Scand 2008;118(4):218-25.
32. Larsson HB, Thomsen C, Frederiksen J, Stubgaard M, Henriksen O. In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis. Magn Reson Imaging 1992;10(1):7-12.
33. Liu Y, Duan Y, He Y, Yu C, Wang J, Huang J, et al. A tract-based diffusion study of cerebral white matter in neuromyelitis optica reveals widespread pathological alterations. Mult Scler 2012;18(7):1013-21.
34. Liang P, Liu Y, Jia X, Duan Y, Yu C, Qin W, et al. Regional homogeneity changes in patients with neuromyelitis optica revealed by resting-state functional MRI. Clin Neurophysiol 2011;122(1):121-7.
35. Liu Y, Liang P, Duan Y, Jia X, Wang F, Yu C, et al. Abnormal baseline brain activity in patients with neuromyelitis optica: a resting-state fMRI study. Eur J Radiol 2011;80(2):407-11.
36. Merle H, Olindo S, Bonnan M, Donnio A, Richer R, Smadja D, et al. Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology 2007;114(4):810-5.
37. McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M, et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008;71(2):93-100.
38. Matthews LA, Baig F, Palace J, Turner MR. The borderland of neuromyelitis optica. Pract Neurol 2009;9(6):335-40.
39. Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 2008;14(9):1157-74.
40. Miller DH, Newton MR, van der Poel JC, du Boulay EP, Halliday AM, Kendall BE, et al. Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology 1988;38(2):175-9. (Pubitemid 18036831)
41. Matthews L, Marasco R, Jenkinson M, Kuker W, Luppe S, Leite MI, et al. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology 2013;80(14):1330-7.
42. Matsushita T, Isobe N, Piao H, Matsuoka T, Ishizu T, Doi H, et al. Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status. J Neurol Sci 2010;291(1-2):37-43.
43. Nakamura M, Miyazawa I, Fujihara K, Nakashima I, Misu T, Watanabe S, et al. Preferential spinal central gray matter involvement in neuromyelitis optica. an MRI study. J Neurol 2008;255(2):163-70.
44. Nakamura M, Misu T, Fujihara K, Miyazawa I, Nakashima I, Takahashi T, et al. Occurrence of acute large and edematous callosal lesions in neuromyelitis optica. Mult Scler 2009;15(6):695-700.
45. O'Riordan JI, Losseff NA, Phatouros C, Thompson AJ, Moseley IF, MacManus DG, et al. Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination. J Neurol Neurosurg Psychiatry 1998;64(3):353-7. (Pubitemid 28159840)
46. O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ, et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 1996;60(4):382-7. (Pubitemid 26118744)
47. Palace J, Leite MI, Nairne A, Vincent A. Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol 2010;67(8):1016-7.
48. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 2008;65(1):78-83.
49. Pirko I, Blauwet LA, Lesnick TG, Weinshenker BG. The natural history of recurrent optic neuritis. Arch Neurol 2004;61(9):1401-5. (Pubitemid 39202223)
50. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006a;63(3):390-6.
51. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302.
52. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006b;63(7):964-8. (Pubitemid 44036298)
53. Poppe AY, Lapierre Y, Melancon D, Lowden D, Wardell L, Fullerton LM, et al. Neuromyelitis optica with hypothalamic involvement. Mult Scler 2005;11(5):617-21. (Pubitemid 41387709)
54. Popescu BF, Lennon VA, Parisi JE, Howe CL, Weigand SD, Cabrera-Gomez JA, et al. Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology 2011;76(14):1229-37.
55. Pichiecchio A, Tavazzi E, Poloni G, Ponzio M, Palesi F, Pasin M, et al. Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach. Mult Scler 2012;18(6):817-24.
56. Qiu W, Wu JS, Zhang MN, Matsushita T, Kira JI, Carroll WM, et al. Longitudinally extensive myelopathy in Caucasians: a West Australian study of 26 cases from the Perth Demyelinating Diseases Database. J Neurol Neurosurg Psychiatry 2010;81(2):209-12.
57. Qian W, Chan Q, Mak H, Zhang Z, Anthony MP, Yau KK, et al. Quantitative assessment of the cervical spinal cord damage in neuromyelitis optica using diffusion tensor imaging at 3 T. J Magn Reson Imaging 2011;33(6):1312-20.
58. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007;130(Pt 5):1194-205. (Pubitemid 47355941)
59. Rizzo III JF, Andreoli CM, Rabinov JD. Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2002;109(9):1679-84. (Pubitemid 35012012)
60. Rocca MA, Agosta F, Mezzapesa DM, Martinelli V, Salvi F, Ghezzi A, et al. Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica. Neurology 2004a;62(3):476-8. (Pubitemid 38200865)
61. Rocca MA, Agosta F, Mezzapesa DM, Falini A, Martinelli V, Salvi F, et al. A functional MRI study of movement-associated cortical changes in patients with Devic's neuromyelitis optica. NeuroImage 2004b;21(3):1061-8. (Pubitemid 38314969)
62. Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 2010;17(8):1019-32.
63. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage 2006;31(4):1487-505.
64. Tortorella P, Rocca MA, Mezzapesa DM, Ghezzi A, Lamantia L, Comi G, et al. MRI quantification of gray and white matter damage in patients with early-onset multiple sclerosis. J Neurol 2006;253(7):903-7. (Pubitemid 44100444)
65. Waters PJ, McKeon A, Leite MI, Rajasekharan S, Lennon VA, Villalobos A, et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012;78(9):665-71. (discussion 9).
66. Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA, Weinshenker BG. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology 2007;68(8):603-5.
67. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66(10):1485-9. (Pubitemid 43958540)
68. Wingerchuk DM. Diagnosis and treatment of neuromyelitis optica. Neurologist 2007;13(1):2-11. (Pubitemid 46095579)
69. Waters P, Jarius S, Littleton E, Leite MI, Jacob S, Gray B, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 2008;65(7):913-9. (Pubitemid 352008474)
70. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53(5):1107-14. (Pubitemid 29442132)
71. Wang F, Liu Y, Duan Y, Li K, Brain MRI. abnormalities in neuromyelitis optica. Eur J Radiol 2011;80(2):445-9.
72. Yu CS, Lin FC, Li KC, Jiang TZ, Zhu CZ, Qin W, et al. Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica. AJNR: Am J Neuroradiol 2006;27(5):1009-15. (Pubitemid 44897677)
73. Yu CS, Zhu CZ, Li KC, Xuan Y, Qin W, Sun H, et al. Relapsing neuromyelitis optica and relapsing-remitting multiple sclerosis: differentiation at diffusion-tensor MR imaging of corpus callosum. Radiology 2007;244(1):249-56. (Pubitemid 46981980)
74. Yu C, Lin F, Li K, Jiang T, Qin W, Sun H, et al. Pathogenesis of normal-appearing white matter damage in neuromyelitis optica: diffusion-tensor MR imaging. Radiology 2008;246(1):222-8. (Pubitemid 350305047)